SCHEMBL6218521

SCHEMBL6218521

CCCCN(C)CC(=O)CNc1ccc(C(=O)Nc2ccc(C)cc2C(=O)Nc2ccc(Cl)cn2)cc1

nearest known ligand 0.63

Predicted protein targets (top 3)

geneUniProtsupporting neighboursconfidence
F10 P00742 19/20 0.63
KLKB1 P03952 2/20 0.56
KCNH2 Q12809 2/20 0.54

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6217674 0.92 F10 (0.63) F10KLKB1KCNH2
SCHEMBL6217486 0.90 F10 (0.63) F10KLKB1
SCHEMBL6106678 0.86 F10 (0.69) F10KLKB1KCNH2
SCHEMBL6215501 0.83 F10 (0.70) F10KLKB1KCNH2
SCHEMBL2431132 0.82 F10 (0.73) F10KLKB1KCNH2
SCHEMBL6105601 0.82 F10 (0.70) F10KLKB1KCNH2
SCHEMBL6214943 0.80 F10 (0.72) F10KLKB1KCNH2
SCHEMBL2433780 0.78 F10 (0.73) F10KLKB1KCNH2
SCHEMBL799840 0.78 F10 (1.00) F10KCNH2
SCHEMBL6108061 0.78 F10 (0.77) F10KLKB1KCNH2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1465892-A4 GLYCINAMIDES AS FACTOR XA INHIBITORS BRISTOL MYERS SQUIBB CO (US) 2005-11-30 EP claimed
EP-1465892-A1 GLYCINAMIDES AS FACTOR XA INHIBITORS Bristol-Myers Squibb Company (US) 2004-10-13 EP claimed
WO-2003048158-A1 GLYCINAMIDES AS FACTOR XA INHIBITORS BRISTOL-MYERS SQUIBB COMPANY (US) 2003-06-12 WO claimed
WO-2003048081-A2 GLYCINAMIDES AS FACTOR XA INHIBITORS BRISTOL-MYERS SQUIBB COMPANY (US) 2003-06-12 WO claimed
WO-2003048081-A2 GLYCINAMIDES AS FACTOR XA INHIBITORS BRISTOL-MYERS SQUIBB COMPANY (US) 2003-06-12 WO disclosed